.. État-des-lieux-de-la-prescription, 269 2.1.4.19 La délivrance des médicaments, p.279

F. Classement-des, 469 4.1.4.19 En fonction de leur fréquence, p.489

J. Olié, F. Elomari, C. Spadone, and J. Lépine, [Antidepressants consumption in the global population in France], Encephale. oct, vol.28, issue.5, pp.411-417, 2002.

I. Gasquet, L. Nègre-pagès, A. Fourrier, G. Nachbaur, A. El-hasnaoui et al., Usage des psychotropes et troubles psychiatriques en France : r??sultats de l?????tude ??pid??miologique ESEMeD/MHEDEA 2000/ (ESEMeD) en population g??n??rale, L'Enc??phale, vol.31, issue.2, pp.195-206, 2005.
DOI : 10.1016/S0013-7006(05)82386-3

J. Alonso, M. Angermeyer, S. Bernert, R. Bruffaerts, T. Brugha et al., Psychotropic drug utilization in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project, Acta Psychiatr Scand, issue.420, pp.55-64, 2004.

J. Lépine and I. Gasquet, Psychotropic drug use in France: changes over time and comparison with other European countries], Bull. Acad. Natl. Med. juin, vol.190, issue.6, pp.1139-1144, 2006.

Y. Chen, C. Kelton, Y. Jing, J. Guo, X. Li et al., Utilization, price, and spending trends for antidepressants in the US Medicaid program, Research in Social and Administrative Pharmacy, vol.4, issue.3, pp.244-257, 2008.
DOI : 10.1016/j.sapharm.2007.06.019

S. Tardieu, A. Bottero, P. Blin, M. Bohbot, S. Goni et al., Roles and practices of general practitioners and psychiatrists in management of depression in the community, BMC Family Practice, vol.1, issue.7, pp.5-71, 2006.
DOI : 10.1016/S0140-6736(94)90515-0

URL : https://hal.archives-ouvertes.fr/inserm-00089192

E. Piek, K. Van-der-meer, W. Hoogendijk, B. Penninx, and W. Nolen, Most Antidepressant Use in Primary Care Is Justified; Results of the Netherlands Study of Depression and Anxiety, PLoS ONE, vol.59, issue.3, p.14784, 2011.
DOI : 10.1371/journal.pone.0014784.t003

J. Stewart, D. Deliyannides, D. Hellerstein, P. Mcgrath, and J. Stewart, Can People With Nonsevere Major Depression Benefit From Antidepressant Medication?, The Journal of Clinical Psychiatry, vol.73, issue.04, pp.518-525, 2012.
DOI : 10.4088/JCP.10m06760

J. Fournier, R. Derubeis, S. Hollon, S. Dimidjian, J. Amsterdam et al., Antidepressant Drug Effects and Depression Severity, JAMA, vol.303, issue.1, pp.47-53, 2010.
DOI : 10.1001/jama.2009.1943

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712503

A. Mercier, I. Auger-aubin, J. Lebeau, P. Royen, and L. Peremans, Understanding the prescription of antidepressants: a Qualitative study among French GPs, BMC Family Practice, vol.8, issue.Suppl 2, p.99, 2011.
DOI : 10.1370/afm.1113

URL : https://hal.archives-ouvertes.fr/inserm-00629907

R. Mojtabai and M. Olfson, Proportion Of Antidepressants Prescribed Without A Psychiatric Diagnosis Is Growing, Health Affairs, vol.30, issue.8, pp.1434-1442, 2011.
DOI : 10.1377/hlthaff.2010.1024

H. Lôo and J. Olié, Effets th??rapeutiques et indications des antid??presseurs, EMC - Psychiatrie, vol.1, issue.4, pp.273-283, 2004.
DOI : 10.1016/j.emcps.2004.05.005

P. Moja, C. Cusi, R. Sterzi, and C. Canepari, Selective serotonin re-uptake inhibitors (SSRIs) for preventing migraine and tension-type headaches, Cochrane Database Syst Rev, vol.3, issue.2, p.2919, 2005.
DOI : 10.1002/14651858.CD002919.pub2

S. Schutte-rodin, L. Broch, D. Buysse, C. Dorsey, and M. Sateia, Clinical guideline for the evaluation and management of chronic insomnia in adults, J Clin Sleep Med. 15 oct, vol.4, issue.5, pp.487-504, 2008.

. Haute-autorité-de-santé, Quelle place pour la prégabaline dans les douleurs neuropathiques1?, Disponible sur, 2007.

P. Dharmshaktu, V. Tayal, and B. Kalra, Efficacy of Antidepressants as Analgesics: A Review, The Journal of Clinical Pharmacology, vol.112, issue.Suppl, pp.6-17, 2012.
DOI : 10.1177/0091270010394852

V. Bril, J. England, G. Franklin, M. Backonja, J. Cohen et al., Evidence-based Guideline: Treatment of Painful Diabetic Neuropathy, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy, p.72
DOI : 10.1016/j.pmrj.2011.03.008

M. Lunn, R. Hughes, and P. Wiffen, Duloxetine for treating painful neuropathy or chronic pain, Cochrane Database Syst Rev, issue.4, p.7115, 2009.
DOI : 10.1002/14651858.cd007115

D. Urquhart, J. Hoving, W. Assendelft, R. M. Van-tulder, and M. , Antidepressants for non-specific low back pain, Cochrane Database Syst Rev, vol.12, issue.1, p.1703, 2008.
DOI : 10.1002/14651858.CD001703.pub3

N. Attal, G. Cruccu, R. Baron, M. Haanpää, P. Hansson et al., EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision, European Journal of Neurology, vol.138, issue.Suppl, pp.1113-88, 2010.
DOI : 10.1111/j.1468-1331.2010.02999.x

K. Anand, V. Dhikav, A. Prasad, and . Shewtengna, Efficacy, safety and tolerability of duloxetine in idiopathic trigeminal neuralgia, J Indian Med Assoc. avr, vol.109, issue.4, pp.264-266, 2011.

M. Alviar, T. Hale, and M. Dungca, Pharmacologic interventions for treating phantom limb pain, Cochrane Database Syst Rev, issue.12, p.6380, 2011.

J. Zakrzewska, H. Forssell, and A. Glenny, Interventions for the treatment of burning mouth syndrome, Cochrane Database Syst Rev, vol.77, issue.3, p.2779, 2005.
DOI : 10.1002/14651858.CD002779.pub2

D. Seitz, N. Adunuri, S. Gill, A. Gruneir, N. Herrmann et al., Antidepressants for agitation and psychosis in dementia, Cochrane Database Syst Rev, issue.2, p.8191, 2011.

S. Ghazi-noori, T. Chung, K. Deane, H. Rickards, and C. Clarke, Therapies for depression in Parkinson’s disease, Cochrane Database of Systematic Reviews [Internet], 1996.

Y. Chen, N. Patel, J. Guo, and S. Zhan, Antidepressant prophylaxis for poststroke depression: a meta-analysis, International Clinical Psychopharmacology, vol.22, issue.3, pp.159-166, 2007.
DOI : 10.1097/YIC.0b013e32807fb028

F. Chollet, J. Tardy, J. Albucher, C. Thalamas, E. Berard et al., Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial, The Lancet Neurology, vol.10, issue.2, pp.123-130, 2011.
DOI : 10.1016/S1474-4422(10)70314-8

F. Chollet, B. Acket, N. Raposo, J. Albucher, I. Loubinoux et al., Use of Antidepressant Medications To Improve Outcomes After Stroke, Current Neurology and Neuroscience Reports, vol.87, issue.7, p.318, 2013.
DOI : 10.1007/s11910-012-0318-z

R. Hoque, A. Chesson, and . Jr, Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis, J Clin Sleep Med. 15 févr, vol.6, issue.1, pp.79-83, 2010.

P. Baldo, C. Doree, R. Lazzarini, P. Molin, and D. Mcferran, Antidepressants for patients with tinnitus, Cochrane Database Syst Rev, issue.4, p.3853, 2006.

J. Brown, P. O’-brien, J. Marjoribanks, and K. Wyatt, Selective serotonin reuptake inhibitors for premenstrual syndrome, Cochrane Database Syst Rev, issue.2, p.1396, 2009.

N. Shah, J. Jones, J. Aperi, R. Shemtov, A. Karne et al., Selective Serotonin Reuptake Inhibitors for Premenstrual Syndrome and Premenstrual Dysphoric Disorder, Obstetrics & Gynecology, vol.111, issue.5, pp.1175-1182, 2008.
DOI : 10.1097/AOG.0b013e31816fd73b

G. Rada, D. Capurro, T. Pantoja, J. Corbalán, G. Moreno et al., Nonhormonal interventions for hot flushes in women with a history of breast cancer, Cochrane Database Syst Rev, issue.9, p.4923, 2010.

P. Mariappan, A. Alhasso, Z. Ballantyne, A. Grant, and J. N’dow, Duloxetine, a Serotonin and Noradrenaline Reuptake Inhibitor (SNRI) for the Treatment of Stress Urinary Incontinence: A Systematic Review, European Urology, vol.51, issue.1, pp.67-74, 2007.
DOI : 10.1016/j.eururo.2006.08.041

. National-guideline-clearinghouse, Incontinence in women In: Guidelines on urinary incontinence) 2010 addendum to 2009 urinary incontinence guidelines

C. Roxburgh, J. Cook, and N. Dublin, Anticholinergic drugs versus other medications for overactive bladder syndrome in adults, Cochrane Database Syst Rev, vol.10, issue.1, p.3190, 2007.
DOI : 10.1002/14651858.CD003190.pub4

A. Moreland and E. Makela, Selective Serotonin-Reuptake Inhibitors in the Treatment of Premature Ejaculation, Annals of Pharmacotherapy, vol.3, issue.7-8, pp.7-81296, 2005.
DOI : 10.1345/aph.1D214

C. Mcmahon, Dapoxetine: a new option in the medical management of premature ejaculation, Therapeutic Advances in Urology, vol.58, issue.5, pp.233-251, 2012.
DOI : 10.1111/j.1743-6109.2010.01782.x

K. Hatzimouratidis, E. Amar, I. Eardley, F. Giuliano, D. Hatzichristou et al., Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation, European Urology, vol.57, issue.5, pp.804-814, 2010.
DOI : 10.1016/j.eururo.2010.02.020

R. Rahimi, S. Nikfar, A. Rezaie, and M. Abdollahi, Efficacy of tricyclic antidepressants in irritable bowel syndrome: A meta-analysis, World Journal of Gastroenterology, vol.15, issue.13, pp.1548-1553, 2009.
DOI : 10.3748/wjg.15.1548

A. Ford, N. Talley, P. Schoenfeld, E. Quigley, and P. Moayyedi, Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis, Gut, vol.58, issue.3, pp.367-378, 2009.
DOI : 10.1136/gut.2008.163162

L. Ruepert, A. Quartero, N. De-wit, G. Van-der-heijden, G. Rubin et al., Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome, Cochrane Database Syst Rev, vol.68, issue.18, p.3460, 2011.
DOI : 10.1002/14651858.CD003460.pub3

J. Hughes, L. Stead, and T. Lancaster, Antidepressants for smoking cessation, Cochrane Database Syst Rev, issue.1, p.31, 2007.

M. Lima, A. Reisser, B. Soares, and M. Farrell, Antidepressants for cocaine dependence, Cochrane Database Syst Rev, issue.2, p.2950, 2003.

E. France, Disponible sur: http://www.ecosante.fr/index2.php?base=FRAN&langh=FRA&langs=FRA&ses sionid= 53, 2013.

S. Baik, J. Gonzales, B. Bowers, J. Anthony, B. Tidjani et al., Reinvention of Depression Instruments by Primary Care Clinicians, The Annals of Family Medicine, vol.8, issue.3, pp.224-230, 2010.
DOI : 10.1370/afm.1113

E. Stolper, M. Van-de-wiel, P. Van-royen, M. Van-bokhoven, T. Van-der-weijden et al., Gut Feelings as a Third Track in General Practitioners??? Diagnostic Reasoning, Journal of General Internal Medicine, vol.41, issue.3, pp.197-203, 2011.
DOI : 10.1007/s11606-010-1524-5

E. Van-geffen, E. Heerdink, J. Hugtenburg, F. Siero, A. Egberts et al., Patients' perceptions and illness severity at start of antidepressant treatment in general practice, International Journal of Pharmacy Practice, vol.46, issue.suppl 22, pp.217-225, 2010.
DOI : 10.1111/j.2042-7174.2010.00035.x

J. Hyde, M. Calnan, L. Prior, G. Lewis, D. Kessler et al., A qualitative study exploring how GPs decide to prescribe antidepressants, Br J Gen Pract. oct, vol.55, issue.519, pp.755-762, 2005.

M. Moore, H. Yuen, N. Dunn, M. Mullee, J. Maskell et al., Explaining the rise in antidepressant prescribing: a descriptive study using the general practice research database, BMJ, vol.339, issue.oct15 2, p.3999, 2009.
DOI : 10.1136/bmj.b3999

T. Oksanen, J. Vahtera, H. Westerlund, J. Pentti, N. Sjösten et al., Is Retirement Beneficial for Mental Health?, Epidemiology, vol.22, issue.4, pp.553-559, 2011.
DOI : 10.1097/EDE.0b013e31821c41bd

R. Rosner, G. Pfoh, and M. Kotoucova, Treatment of complicated grief, Disponible sur, 3402114.
DOI : 10.1080/07481180600614385

C. Ludmila, Antidépresseurs1: quels sont les facteurs de prescription1? Entretien de Bichat, Disponible, vol.sur, 2004.